Details of the Drug
General Information of Drug (ID: DMABITD)
Drug Name |
Tetradecyl-phosphonic acid
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
Tetradecylphosphonic acid; 4671-75-4; Phosphonic acid, tetradecyl-; 1-Tetradecanephosphonic acid; Tetradecanephosphonic acid; Tetradecyl phosphonic acid; n-Tetradecylphosphonic acid; 1-Tetradecylphosphonic Acid; Phosphonic acid, P-tetradecyl-; EINECS 225-118-1; BRN 1784271; CHEMBL190999; P-tetradecyl-Phosphonic acid; C14H31O3P; tetradecylphosphonate; AC1L2V5G; 14; SCHEMBL19906; 4-04-00-03566 (Beilstein Handbook Reference); Tetradecylphosphonic acid, 97%; DTXSID7063550; CTK3J7960
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 2 | Molecular Weight (mw) | 278.37 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 5.1 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 13 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||